MOH Does Not Intervene in Insurers’ Commercial Decisions: Rahayu Mahzam

Why It Matters

Understanding MOH’s limited role in premium setting helps consumers anticipate price trends and underscores the need for insurers to price sustainably, protecting long‑term market stability.

Key Takeaways

• MOH regulates IP co-payments but not insurers' premium pricing.
• Premium hikes mirror rising healthcare costs and over‑servicing.
• MOH intervenes only via consumer protection conditions, not commercial decisions.
• Artificial price caps could trigger benefit cuts or insurer market exits.
• Sustainable insurance requires insurers to reprice amid cost pressures.

Summary

In a recent briefing, Health Minister Rahayu Mahzam clarified that Singapore’s Ministry of Health (MOH) sets the core parameters of Integrated Shield (IP) and Rider policies—such as co‑payments and deductibles—but deliberately refrains from dictating insurers’ premium levels. The ministry’s stance is to let insurers operate as commercial entities, ensuring competition while maintaining a measured regulatory presence focused on consumer safeguards.

Mahzam highlighted that premium increases are not arbitrary; they reflect escalating healthcare expenditures, over‑consumption, and overservicing driven by overly generous product designs. These cost pressures translate into higher claim payouts, which in turn force insurers to raise premiums to stay solvent. The MOH argues that artificially capping prices would jeopardise the long‑term viability of the schemes, potentially leading to reduced benefits or even insurer market exits.

The minister underscored that MOH’s engagement with insurers remains robust, but it draws a clear line at commercial pricing decisions. She warned that imposing price limits could backfire, harming policyholders through diminished coverage or reduced insurer participation. The emphasis is on a sustainable pricing model where insurers adjust rates in line with genuine cost trends.

For consumers, the message signals that rising premiums are likely to continue unless underlying cost drivers are addressed. Insurers must balance competitiveness with financial prudence, while regulators will monitor consumer protection aspects without stifling market dynamics. The dialogue suggests a continued focus on aligning insurance pricing with actual healthcare cost trajectories.

Original Description

Minister of State Rahayu Mahzam said in Parliament on May 6 that the Ministry of Health will not intervene in private insurers’ commercial decisions, such as setting of premiums, noting that artificial price caps are unsustainable and could jeopardise insurers’ ability to meet claims.

Read more: https://bt.sg/dE8o

Support us:

https://subscribe.sph.com.sg/publications-bt/